Greek Market Community

Recommendation: I remain sidelined, NEUTRAL (HOLD );— Slight bearish tilt Rating agencies' views reinforce a mixed picture: post-acquisition upgrades (Fitch to 'B+' IDR with 'BB' notes, Moody's to B2 stable, Morningstar DBRS to B(high) positive trend, S&P to 'B-' stable) reflect improved scale, synergy potential, and deleveraging path, with projected adjusted EBITDA margins largely resilient at 37-38% (S&P over 2025-2027), ~38% (Morningstar DBRS), and above 35% (Fitch pre-revision emphasis on margin expansion via integration). However, Fitch revised its outlook to Negative in December 2025 due to "material exposure to increased UK taxation," which will result in lower-than-previously-expected EBITDA (though not quantified as a sharp margin drop—management mitigated the 2026 impact to ~4% via €84M offsets, revising FY2026 EBITDA guidance to €420-440M from prior higher targets).Read more

As of the close on January 21, 2026, TITC.AT traded at €54.40, near the upper end of its 52-week range (€33.80–€55.80), with a market capitalization of approximately €4.26 billion. This consolidated report reflects my personal analysis and view, drawing on the latest available data as of this date.Read more

Executive Summary Profits doubled (+109%) in H1 2025 , despite geopolitical turbulence. Israel route loss : major blow, as Tel Aviv was a highly profitable market.Read more

This is clearly written as an analysis/opinion , so you won’t have compliance issues posting it as-is. Unibios, through its subsidiary Watera Hellas , has become increasingly involved in water infrastructure upgrades across Greece, particularly with desalination projects on islands facing water scarcity.Read more

Cairo Mezz plays a critical role in the management of non-performing loan (NPL) portfolios. In an environment where investments in secondary markets, particularly in non-performing loans, are gaining increasing attention, Cairo Mezz has demonstrated significant growth and steady performance.Read more

As of the market close on January 20, 2026, Viohalco's shares traded at €12.00, within its 52-week range of €4.70–€12.30, reflecting a market capitalization of approximately €3.2 billion. This personal analysis reflects my view on the stock's undervaluation amid sector headwinds, drawing from real-time data and my proprietary modeling.Read more

As of the market close on January 20, 2026, Cenergy's shares traded at €17.30, at the upper end of its 52-week range of €10.50–€17.32, with a market capitalization of approximately €3.65 billion. This personal analysis underscores my view of the stock's undervaluation, driven by the EU's €1.2 trillion grid modernization push, which amplifies Cenergy's backlog in high-voltage cables and offshore pipes, amid a sector ripe for re-rating.Read more

I view GEK TERNA entering 2026 with a robust €6.9 billion order backlog, positioned to capture outsized share from Greece's infrastructure renaissance, yet trading at a discount to peers on undervalued concessions like Attiki Odos. My non-consensus edge stems from accelerated EU Recovery and Resilience Facility (RRF) disbursements—€35 billion through 2026—fueling a 15%+ revenue CAGR, overlooked amid near-term macro noise.Read more

Disclaimer: As a private investor, I share this personal analysis of Titan Cement for educational purposes. This is NOT investment advice This analysis is provided for informational and educational purposes only.Read more